ID   B16V
AC   CVCL_1950
SY   B-16V
DR   CLO; CLO_0001795
DR   CLDB; cl341
DR   DSMZ; ACC-370
DR   DSMZCellDive; ACC-370
DR   Wikidata; Q54752528
RX   PubMed=3730255;
CC   Doubling time: 15 +- 1.64 hours (PubMed=3730255); ~20 hours (DSMZ=ACC-370).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F936 ! B16
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
RX   PubMed=3730255; DOI=10.1038/bjc.1986.149;
RA   Supino R., Prosperi E., Formelli F., Mariani M., Parmiani G.;
RT   "Characterization of a doxorubicin-resistant murine melanoma line:
RT   studies on cross-resistance and its circumvention.";
RL   Br. J. Cancer 54:33-42(1986).
//